Research location
Luoyang
Henan, China
Advertisement
Research activity in Luoyang
Henan, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 133 trials and 150 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Luoyang
133 linked trials · page 1 of 3A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/ObesityNCT07747857 · 2026-08-25 · 1 site observation
RECRUITING
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsNCT07797335 · 2026-08-24 · 2 site observations
RECRUITING
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUreNCT07687186 · 2026-06-22 · 1 site observation
RECRUITING
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNCT07571109 · 2026-05-05 · 1 site observation
RECRUITING
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)NCT07416474 · 2026-04-03 · 1 site observation
RECRUITING
A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionNCT07367529 · 2026-02-26 · 1 site observation
RECRUITING
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)NCT07363590 · 2026-02-19 · 1 site observation
RECRUITING
A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes MellitusNCT07347080 · 2026-01-20 · 1 site observation
RECRUITING
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT07222566 · 2026-01-06 · 2 site observations
RECRUITING
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsNCT07185997 · 2025-12-17 · 1 site observation
RECRUITING
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)NCT07100080 · 2025-11-05 · 1 site observation
RECRUITING
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerNCT07043725 · 2025-09-15 · 1 site observation
RECRUITING
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsNCT07169994 · 2025-09-02 · 1 site observation
RECRUITING
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2NCT07097818 · 2025-08-18 · 1 site observation
RECRUITING
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver CirrhosisNCT07116096 · 2025-08-17 · 1 site observation
RECRUITING
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerNCT07047365 · 2025-07-25 · 1 site observation
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.NCT06758401 · 2025-07-23 · 1 site observation
RECRUITING
Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast CancerNCT07008976 · 2025-07-07 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
A Study of BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast CancerNCT06891833 · 2025-06-05 · 1 site observation
RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionNCT06829784 · 2025-03-21 · 1 site observation
RECRUITING
Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast CancerNCT06765590 · 2025-03-12 · 1 site observation
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514 · 2025-02-27 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesNCT06839105 · 2025-02-21 · 1 site observation
RECRUITING
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerNCT07673029 · 2025-01-10 · 2 site observations
RECRUITING
Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER StudyNCT07097805 · 2025-01-01 · 1 site observation
RECRUITING
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionNCT06736574 · 2024-12-19 · 1 site observation
RECRUITING
Mobile Applet for Weight Management in Obese Heart Failure PatientsNCT06455878 · 2024-06-06 · 2 site observations
RECRUITING
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNCT06300177 · 2024-03-28 · 1 site observation
RECRUITING
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsNCT05956587 · 2024-01-29 · 1 site observation
RECRUITING
A Study of YL202 in Selected Patients With Advanced Solid TumorsNCT06107686 · 2023-12-15 · 1 site observation
RECRUITING
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)NCT05920356 · 2023-11-16 · 1 site observation
RECRUITING
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.NCT06064812 · 2023-09-12 · 1 site observation
RECRUITING
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsNCT05914116 · 2023-08-17 · 1 site observation
RECRUITING
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast CancerNCT05744687 · 2023-04-24 · 1 site observation
RECRUITING
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerNCT05851014 · 2022-01-14 · 1 site observation
RECRUITING
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 DiabetesNCT05498974 · 2022-01-01 · 1 site observation
RECRUITING
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure PatientsNCT07725484 · 2026-11-01 · 1 site observation
NOT_YET_RECRUITING
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation
NOT_YET_RECRUITING
Treatment Strategy for Patients With RA-ILDNCT07643038 · 2026-09-20 · 1 site observation
NOT_YET_RECRUITING
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityNCT07792954 · 2026-09-01 · 2 site observations
NOT_YET_RECRUITING
A Study of ATG-201 in Adult Participants With Autoimmune DiseasesNCT07732309 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing PrediabetesNCT07558525 · 2026-04-18 · 1 site observation
NOT_YET_RECRUITING
Probiotic for Weight Management in Overweight and Obese AdultsNCT07507929 · 2026-03-20 · 1 site observation
NOT_YET_RECRUITING
Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or ObesityNCT07804797 · 2026-03-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)NCT07230119 · 2026-01-16 · 2 site observations
ACTIVE_NOT_RECRUITING
Phase 2 Study of MWN109 Tablet in Participants With Overweight or ObesityNCT07791524 · 2026-01-05 · 1 site observation
COMPLETED
Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With OverweightNCT07791537 · 2025-12-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast CancerNCT07246317 · 2025-12-15 · 1 site observation
NOT_YET_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.